SCHEMBL17209016

SCHEMBL17209016

COc1cccc(-n2c(C)ccc2C)c1P(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 2/20 0.41
MYC P01106 4/20 0.40
NR4A1 P22736 2/20 0.40
GAA P10253 3/20 0.39
HTT P42858 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.38
AVPR2 P30518 1/20 0.38
AVPR1A P37288 1/20 0.38
HTR6 P50406 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17199827 0.85 ALDH1A1 (0.41) KDM4EALDH1A1MAPTHTTMEN1
Hydrochloric Acid SCHEMBL17200831 0.82 ALDH1A1 (0.39) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL17529705 0.80 CA1 (0.50) KDM4EALDH1A1MAPTLMNAHTT
SCHEMBL20697880 0.77 CA1 (0.43) KDM4EALDH1A1MAPTLMNAHTT
SCHEMBL17212364 0.77 MAPT (0.41) KDM4EALDH1A1MAPTLMNAMYC
SCHEMBL17212363 0.77 MAPT (0.41) KDM4EALDH1A1MAPTLMNAMYC
SCHEMBL21354434 0.76 ALDH1A1 (0.58) KDM4EALDH1A1MAPTLMNAMYC
SCHEMBL10700691 0.76 CA1 (0.50) KDM4EALDH1A1MAPTLMNAHTT
SCHEMBL14687882 0.73 MAPT (0.42) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL19058810 0.72 ALDH1A1 (0.40) ALDH1A1MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2937355-B1 PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME TAKASAGO PERFUMERY CO LTD (JP) 2017-06-28 EP disclosed
US-9416148-B2 Phosphorus compound and transition metal complex of the same TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-08-16 US disclosed
US-9416148-B2 Phosphorus compound and transition metal complex of the same TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-08-16 US disclosed
US-20150307531-A1 PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-10-29 US disclosed
US-20150307531-A1 PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-10-29 US disclosed
EP-2937355-A1 PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME Takasago International Corporation (JP) 2015-10-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307531-A1 PHOSPHORUS COMPOUND AND TRANSITION METAL COMPLEX OF THE SAME P2RY10, PTH1R, INPP5A KDM4E 3631/4885ALDH1A1 4695/4885MAPT 3950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.